These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 36223531)
1. Stakeholders' solutions to antiretroviral therapy interruption during the COVID-19 pandemic in China: a short report. Zhan Y; Sun Y; Feng A; Li H; Gao Y; Liu Y; Fitzpatrick T; Liang B; Fu L; Wang B; Wu D; Zhai X; Fang Y; Zheng W; Zou H AIDS Care; 2023 May; 35(5):634-638. PubMed ID: 36223531 [TBL] [Abstract][Full Text] [Related]
2. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study. Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study. Sun Y; Li H; Luo G; Meng X; Guo W; Fitzpatrick T; Ao Y; Feng A; Liang B; Zhan Y; Sande A; Xie F; Wang Y; Qian HZ; Cai Y; Zou H J Int AIDS Soc; 2020 Nov; 23(11):e25637. PubMed ID: 33247541 [TBL] [Abstract][Full Text] [Related]
4. Barriers to access to antiretroviral therapy by people living with HIV in an indonesian remote district during the COVID-19 pandemic: a qualitative study. Fauk NK; Gesesew HA; Seran AL; Ward PR BMC Infect Dis; 2023 May; 23(1):296. PubMed ID: 37147599 [TBL] [Abstract][Full Text] [Related]
5. Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID-19. Bachanas PJ; Chun HM; Mehta N; Aberle-Grasse J; Parris K; Sherlock MW; Lloyd S; Zeh C; Makwepa DK; Kapanda ML; Dokubo EK; Bonono L; Balachandra S; Ehui E; Fonjungo P; Nkoso AM; Mazibuko S; Okello VN; Tefera F; Getachew M; Katiku EM; Mulwa A; Asiimwe FM; Tarumbiswa TF; Auld AF; Nyirenda R; Dos Santos De Louvado AP; Gaspar I; Hong SY; Ashipala L; Obanubi C; Ikpeazu A; Musoni C; Yoboka E; Mthethwa S; Pinini Z; Bunga S; Rumunu J; Magesa DJ; Mutayoba B; Nelson LJ; Katureebe C; Agolory S; Mulenga LB; Nyika P; Mugurungi O; Ellerbrock T; Mitruka K J Int AIDS Soc; 2022 Nov; 25(11):e26033. PubMed ID: 36419346 [TBL] [Abstract][Full Text] [Related]
6. Expanding access to HIV services during the COVID-19 pandemic-Nigeria, 2020. Boyd AT; Jahun I; Dirlikov E; Greby S; Odafe S; Abdulkadir A; Odeyemi O; Dalhatu I; Ogbanufe O; Abutu A; Asaolu O; Bamidele M; Onyenuobi C; Efuntoye T; Fagbamigbe JO; Ene U; Fagbemi A; Tingir N; Meribe C; Ayo A; Bassey O; Nnadozie O; Boyd MA; Onotu D; Gwamna J; Okoye M; Abrams W; Alagi M; Oladipo A; Williams-Sherlock M; Bachanas P; Chun H; Carpenter D; Miller DA; Ijeoma U; Nwaohiri A; Dakum P; Mensah CO; Aliyu A; Oyeledun B; Okonkwo P; Oko JO; Ikpeazu A; Aliyu G; Ellerbrock T; Swaminathan M AIDS Res Ther; 2021 Sep; 18(1):62. PubMed ID: 34538268 [TBL] [Abstract][Full Text] [Related]
7. [Quick community survey on the impact of COVID-19 outbreak for the healthcare of people living with HIV]. Guo W; Weng HL; Bai H; Liu J; Wei XN; Zhou K; Sande A Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):662-666. PubMed ID: 32223840 [No Abstract] [Full Text] [Related]
8. Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data. Sanwo O; Persaud NE; Nwaokoro P; Idemudia A; Akpan U; Toyo O; Imohi P; Badru T; Obiora-Okafo C; Uzochukwu CE; Aliu O; Olatunbosun K; Pandey SR; Khamofu H; Chiegil R; James E; Iyortim I; Oqua D; Bateganya M J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25820. PubMed ID: 34713591 [TBL] [Abstract][Full Text] [Related]
9. Distribution of antiretroviral therapy through private pharmacies and postal courier services during COVID-19 in Botswana: acceptability and reach of two out-of-facility individual differentiated service delivery models. Mpofu M; Moyo T; Gilbert M; Dikobe W; Nishimoto L; Katiko G; Batuka J; Satti H; Qambayot M; Mahler H; Kitso L; Marqusee H; Bateganya M J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25814. PubMed ID: 34713589 [TBL] [Abstract][Full Text] [Related]
10. A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs. Fleming T; Collins AB; Bardwell G; Fowler A; Boyd J; Milloy MJ; Small W; McNeil R PLoS One; 2021; 16(2):e0246999. PubMed ID: 33635886 [TBL] [Abstract][Full Text] [Related]
11. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV. Matza LS; Paulus TM; Garris CP; Van de Velde N; Chounta V; Deger KA Patient; 2020 Aug; 13(4):409-422. PubMed ID: 32356146 [TBL] [Abstract][Full Text] [Related]
12. Exploring the barriers to the antiretroviral therapy adherence among people living with HIV in Bangladesh: A qualitative approach. Hossain F; Hasan M; Begum N; Mohan D; Verghis S; Jahan NK PLoS One; 2022; 17(10):e0276575. PubMed ID: 36269716 [TBL] [Abstract][Full Text] [Related]
13. The impact of the COVID-19 pandemic on people living with HIV: a cross-sectional study in Caracas, Venezuela. Forero-Peña DA; Carrión-Nessi FS; Forero-Peña JL; Camejo-Ávila NA; Mendoza-Millán DL; Omaña-Ávila ÓD; Maricuto AL; Velásquez VL; Mejía-Bernard MD; Rodriguez-Saavedra CM; Marcano-Rojas MV; Contreras Y; Guerra LJ; Alvarado MF; Carballo M; Caldera J; Guevara RN; Redondo MC; Landaeta ME BMC Infect Dis; 2024 Jan; 24(1):87. PubMed ID: 38225550 [TBL] [Abstract][Full Text] [Related]
14. The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India. Marbaniang I; Sangle S; Nimkar S; Zarekar K; Salvi S; Chavan A; Gupta A; Suryavanshi N; Mave V BMC Public Health; 2020 Oct; 20(1):1598. PubMed ID: 33097028 [TBL] [Abstract][Full Text] [Related]
15. A case study of HIV/AIDS services from community-based organizations during COVID-19 lockdown in China. Bouey JZH; Han J; Liu Y; Vuckovic M; Zhu K; Zhou K; Su Y BMC Health Serv Res; 2023 Mar; 23(1):288. PubMed ID: 36973805 [TBL] [Abstract][Full Text] [Related]
16. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study. Musheke M; Bond V; Merten S AIDS Patient Care STDS; 2013 Apr; 27(4):231-41. PubMed ID: 23530573 [TBL] [Abstract][Full Text] [Related]
17. Explorative-descriptive study on the effects of COVID-19 on access to antiretroviral therapy services: the case of a teaching hospital in Ghana. Abraham SAA; Doe PF; Osei Berchie G; Agyare E; Ayisi Addo S; Obiri-Yeboah D BMJ Open; 2022 May; 12(5):e056386. PubMed ID: 35613780 [TBL] [Abstract][Full Text] [Related]
18. Effect of Late Testing and Antiretroviral Treatment on Mortality Among People Living With HIV in the Era of Treat-All in Guangdong Province, China, 1992-2018: A Cohort Study. Chen Q; Liu J; Fu X; Yang F; Liu Q; Li J; Tan Z; Li J; Lin K; Yan Y; Yang Y; Li Y; Jiang H Front Public Health; 2022; 10():851117. PubMed ID: 35875008 [TBL] [Abstract][Full Text] [Related]
19. Factors for incomplete adherence to antiretroviral therapy including drug refill and clinic visits among older adults living with human immunodeficiency virus - cross-sectional study in South Africa. Barry A; Ford N; El-Khatib Z Trop Med Int Health; 2018 Mar; 23(3):270-278. PubMed ID: 29243867 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral Therapy Initiation Following Policy Changes: Observations From China. Li L; Ji G; Lin C; Liang LJ; Lan CW Asia Pac J Public Health; 2016 Jul; 28(5):416-22. PubMed ID: 27217427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]